Sign In
Buy ACRX
$0.86
+0 (+0%)
At Close: Apr 08, 2024
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3) * Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) * BioMari
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs June 3)
Arena Pharmaceuticals, Inc. (...
Acelrx Pharmaceuticals Will Be Paid a Break-up Fee of ~$1.8M
10:52pm, Wednesday, 03'rd Jun 2020AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
10:51pm, Wednesday, 03'rd Jun 2020AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
10:50pm, Wednesday, 03'rd Jun 2020
AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settin
20 Healthcare Stocks Moving In Tuesday's Pre-Market Session
11:32am, Tuesday, 02'nd Jun 2020AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
01:00am, Tuesday, 02'nd Jun 2020
REDWOOD CITY, Calif., June 1, 2020 /PRNewswire via COMTEX/ --
REDWOOD CITY, Calif., June 1, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX),...
AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
12:00am, Tuesday, 02'nd Jun 2020
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, t
Merger Arbitrage Mondays - The Bidding War For Tetraphase Pharmaceuticals Comes To An End
02:31pm, Monday, 01'st Jun 2020
Merger activity ground to a halt last week with no new deals announced. Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals enter into a second amendment. Tex
Hedge Funds Have Never Been Less Bullish On AcelRx Pharmaceuticals Inc (ACRX)
06:34pm, Friday, 29'th May 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
UPDATE: Tetraphase Announces $37M Valuation, $18.7M In Stock Warrants, In Merger With AcelRx
12:51pm, Friday, 29'th May 2020AcelRx Pharmaceuticals Announces Revised Merger Agreement With Tetraphase
12:35pm, Friday, 29'th May 2020AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
12:30pm, Friday, 29'th May 2020
AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settin
Tetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration
12:00am, Friday, 29'th May 2020
Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline f
